Interpace Biosciences Financials

Based on the key indicators related to Interpace Biosciences' liquidity, profitability, solvency, and operating efficiency, Interpace Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.
With this module, you can analyze Interpace financials for your investing period. You should be able to track the changes in Interpace Biosciences individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Interpace Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Interpace Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Interpace Biosciences' assets may result in an increase in income on the income statement.
The data published in Interpace Biosciences' official financial statements typically reflect Interpace Biosciences' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Interpace Biosciences' quantitative information. For example, before you start analyzing numbers published by Interpace accountants, it's essential to understand Interpace Biosciences' liquidity, profitability, and earnings quality within the context of the Health Care Providers & Services space in which it operates.

Interpace Biosciences Stock Summary

Interpace Biosciences competes with Intelligent Bio, BioAffinity Technologies,, Fonar, Burning Rock, and Sera Prognostics. Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey. Interpace Diag operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 147 people.
Specialization
Healthcare, Diagnostics & Research
InstrumentUSA OTC Stock View All
ExchangeOTCQX Exchange
ISINUS46062X3035
CUSIP69329V100 46062X204 46062X105 46062X303 74312N107
LocationNew Jersey; U.S.A
Business AddressMorris Corporate Center
SectorHealth Care Providers & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.interpacediagnostics.com
Phone855 776 6419
CurrencyUSD - US Dollar

Interpace Biosciences Key Financial Ratios

There are many critical financial ratios that Interpace Biosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Interpace Biosciences reports annually and quarterly.

Interpace Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Interpace Biosciences's current stock value. Our valuation model uses many indicators to compare Interpace Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Interpace Biosciences competition to find correlations between indicators driving Interpace Biosciences's intrinsic value. More Info.
Interpace Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Interpace Biosciences' earnings, one of the primary drivers of an investment's value.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Consideration for investing in Interpace OTC Stock

If you are still planning to invest in Interpace Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Interpace Biosciences' history and understand the potential risks before investing.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format